Abstract:Abstract Background and Aims IgA nephropathy is the most common primary glomerulonephritis worldwide. There is growing evidence of host immunity is closely related to the pathogenesis of IgAN, but the detailed mechanism in the early stages of IgAN remain largely unknown. In this study, we applied single-cell RNA-seq technology to investigate the transcriptomic changes in PBMCs and kidney tissues of early stage IgAN patients at the single-cell resolution. This study aims to establish a immune and kidney cell landscape of IgAN, and offers new insights for the diagnosis and treatment of IgAN. Method In strict accordance to the admission criteria, collect peripheral venous blood and kidney samples of healthy donors and newly diagnosed IgAN patients, prepare single cell solution, verify cell viability by flow cytometry, and perform single-cell RNA-seq using a BD Rhapsody platform. Meanwhile, the clinical data of healthy donors and IgAN patients were collected and analysed. Finally, the correlation and association of differential expressed genes (DEGs) and cell clusters-identified by single-cell RNA-seq with the clinical data of IgAN were investigated. Results First, we established immune cells and kidney cells landscape of IgAN. The differentially expressed genes (DEGs) between the control group and IgAN were mainly concentrated in the NK cell-mediated cytotoxicity and cell killing pathways. Interestingly, we found significant decreases in NK cell numbers and cytotoxicity, and NK cell numbers and marker genes were negatively correlated with clinical parameters, including urinary protein creatinine ratio (UPCR) and serum galactose-deficient IgA1 and IgA. In contrast, B cell DEGs were enriched in different viral infection pathways, and one specific B cell subgroup showed inhibition of NFκB signaling, which was positively correlated with clinical parameters. In addition, a subpopulation of monocytes expressing interferon-inducing genes was positively associated with clinical severity of IgAN. In case of the kidney tissue, compared with the control group, mesangial cells of IgAN patients up-regulated extracellular matrix, transcription factors, kidney development and genes related to the regulation of Wnt signaling pathway. The expression of structural protein ITGA8 on mesangial cells was significantly decreased, indicating the mesangial cells were damaged in early IgAN. Pseudo-time analysis indicated that extracellular matrix-related genes were involved in mesangial cell lesion. We also found that the patie'ts' glomerular endothelial cells expressed high level of angiogenesis and VEGF- related genes. Moreover, podocytes of IgAN patients expressed genes of cytoskeletal recombination and FGFR activation. Conclusion We successfully established the single-cell landscapes of peripheral blood immune cells and kidney cells in early IgAN patients, which revealed changes in the number and status of immune cells and kidney cells closely related to clinical manifestations and phenotypic transformation. Our study offers new insights for the diagnosis and treatment of IgAN.

Unveiling biomarkers and therapeutic targets in IgA nephropathy through large-scale blood transcriptome analysis

Integrated Proteomics and Metabolomics to Study IgA Nephropathy on Early Stage and Identification of Biomarkers

Identifying potential biomarkers for the diagnosis and treatment of IgA nephropathy based on bioinformatics analysis

Identification of Hub Genes and Therapeutic Agents for IgA Nephropathy Through Bioinformatics Analysis and Experimental Validation

Identification of miRNA-mRNA network and immune-related gene signatures in IgA nephropathy by integrated bioinformatics analysis

Functional networks of aging markers in the glomeruli of IgA nephropathy: a new therapeutic opportunity.

Identification of blood-based key biomarker and immune infiltration in Immunoglobulin A nephropathy by comprehensive bioinformatics analysis and a cohort validation

Identification of key genes, pathways and potential therapeutic agents for IgA nephropathy using an integrated bioinformatics analysis

Bioinformatics analysis reveals novel hub gene pathways associated with IgA nephropathy

Identification and validation of glomerulotubular crosstalk genes mediating IgA nephropathy by integrated bioinformatics

Single-cell RNA-sequencing Reveals Distinct Immune Cell Subsets and Signaling Pathways in IgA Nephropathy

Integrated Bioinformatics Analysis Reveals Novel Hub Genes Closely Associated with Pathological Mechanisms of Immunoglobulin A Nephropathy

Identification and Validation of Prognostic Biomarkers Specifically Expressed in Macrophage in IgA Nephropathy Patients Based on Integrated Bioinformatics Analyses

Characteristics of innate and adaptive immune disorder in IgA nephropathy based on integrated bioinformatics

Identification of Potential Biomarkers and Therapeutic Targets for Human IgA Nephropathy and Hypertensive Nephropathy by Bioinformatics Analysis

Comprehensive Analysis of Aberrantly Expressed Profiles of Mrna and Its Relationship with Serum Galactose-Deficient IgA1 Level in IgA Nephropathy

Comprehensive Analysis of ceRNA Network and Immune Cell Infiltration Pattern of Autophagy-Related Genes in IgA Nephropathy

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

Single-Cell Transcriptomics Reveal Immune Mechanisms of the Onset and Progression of IgA Nephropathy.

#3764 SINGLE-CELL RNA-SEQ REVEALS IMMUNE AND KIDNEY CELL TYPE–SPECIFIC MOLECULAR ASSOCIATIONS TO IGA NEPHROPATHY

Exploring the crosstalk molecular mechanisms between IgA nephropathy and Sjögren's syndrome based on comprehensive bioinformatics and immunohistochemical analyses